Equities

Merit Medical Systems Inc

Merit Medical Systems Inc

Actions
  • Price (USD)73.78
  • Today's Change0.40 / 0.55%
  • Shares traded283.44k
  • 1 Year change-5.01%
  • Beta0.9115
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

  • Revenue in USD (TTM)1.26bn
  • Net income in USD94.41m
  • Incorporated1987
  • Employees6.95k
  • Location
    Merit Medical Systems Inc1600 West Merit Park WaySOUTH JORDAN 84095United StatesUSA
  • Phone+1 (801) 253-1600
  • Fax+1 (801) 253-1652
  • Websitehttps://www.merit.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MMSI:NSQ since
announced
Transaction
value
AngioDynamics Inc-Dialysis Catherer Portfolio & BioSentry ProductDeal completed08 Jun 202308 Jun 2023Deal completed-13.44%100.00m
Bluegrass Vascular Technologies Inc-Surfacer Inside-Out Access Catheter SystemDeal completed08 Jun 202308 Jun 2023Deal completed-13.44%32.50m
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Patterson Companies, Inc.6.57bn193.86m2.31bn7.60k12.722.398.250.3522.032.0368.8610.782.235.6114.48864,047.906.580.370211.300.565521.3021.052.950.18110.724312.080.4462846.10-0.42983.442.1410.798.220.00
Tandem Diabetes Care Inc747.72m-222.61m2.33bn2.40k--7.43--3.12-3.44-3.4411.514.780.74572.826.79311,549.20-22.20-10.08-27.07-12.2349.1751.77-29.77-11.593.02--0.4761---6.6832.39-135.33--76.81--
Premier Inc1.32bn167.33m2.49bn2.80k14.931.048.481.891.391.3910.9719.950.35714.573.06470,033.204.4210.395.6713.0067.1362.0412.3722.601.32516.340.243119.11-6.762.44-34.17-15.30-2.29--
Procept Biorobotics Corp136.19m-105.90m2.66bn626.00--9.45--19.56-2.24-2.242.885.530.38151.914.28217,557.50-29.66---33.47--52.17---77.75--6.77--0.1546--81.55---21.51------
TransMedics Group Inc241.62m-25.03m2.93bn584.00--21.25--12.13-0.7685-0.76857.434.200.49152.705.30413,738.00-5.09-16.08-5.53-17.9563.7765.37-10.36-40.478.49--0.7868--158.5379.3630.92--225.12--
LivaNova PLC1.15bn17.55m2.97bn2.90k171.002.3343.812.580.32220.322221.3223.700.48832.765.79397,774.100.7472-6.010.8627-7.4266.8666.991.53-13.562.511.100.3147--12.890.8278120.34---1.64--
Enovis Corp1.71bn-54.37m3.02bn6.55k--0.8818.511.77-0.9987-0.611731.3362.610.38881.596.11260,640.80-1.23-0.3569-1.37-0.4158.2148.19-3.15-1.061.161.020.1199--9.22-4.89-40.29--11.91--
Axonics Inc366.38m-6.09m3.39bn797.00--5.30532.279.26-0.1285-0.12857.4312.560.53131.357.18459,697.60-0.8828-12.67-0.9601-13.7674.9470.04-1.66-29.688.98--0.00--33.86249.0689.80--23.65--
Envista Holdings Corp2.57bn-100.20m3.44bn12.80k--0.822697.191.34-0.6022-0.602214.6524.340.38913.996.41200,507.80-1.521.94-1.792.3456.5257.65-3.905.291.905.120.26610.00-0.1012-2.04-142.10---4.22--
Integer Holdings Corp1.63bn98.09m3.72bn10.50k38.542.4418.712.282.882.8847.8645.520.54524.924.95155,494.603.283.283.533.5326.5226.946.016.402.013.660.43030.0016.035.6238.719.3321.71--
Merit Medical Systems Inc1.26bn94.41m4.26bn6.95k45.363.5323.113.391.621.6221.5520.780.63042.367.34180,916.004.732.455.302.7746.4444.507.513.913.959.890.40640.009.247.3326.7015.86-11.16--
Haemonetics Corporation1.27bn126.57m4.45bn3.03k35.474.7220.243.502.472.4724.8018.570.62292.116.47418,649.006.214.747.055.8953.4849.879.977.411.7626.490.480.0017.675.27166.059.488.06--
Lantheus Holdings Inc1.30bn326.66m4.47bn834.0014.055.4811.563.454.644.6418.5911.910.87239.465.211,554,471.0021.986.6925.757.7363.7153.9025.209.025.451,235.430.40810.0038.6530.441,063.8651.8135.48--
Glaukos Corp314.71m-134.66m5.00bn907.00--10.65--15.90-2.78-2.786.509.400.3241.898.29346,980.20-13.86-8.73-14.99-9.3575.9974.77-42.79-28.694.78-27.680.4335--11.2611.66-35.75--14.44--
Novanta Inc881.66m72.88m5.61bn2.90k77.258.3146.936.362.022.0224.4718.800.71473.046.36304,021.405.915.466.746.3445.3643.248.277.711.914.830.34770.002.417.49-1.588.214.19--
Data as of Apr 26 2024. Currency figures normalised to Merit Medical Systems Inc's reporting currency: US Dollar USD

Institutional shareholders

53.63%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20238.70m15.03%
The Vanguard Group, Inc.as of 31 Dec 20236.72m11.60%
William Blair Investment Management LLCas of 31 Dec 20233.82m6.59%
SSgA Funds Management, Inc.as of 31 Dec 20232.22m3.84%
ArrowMark Colorado Holdings LLCas of 31 Dec 20232.19m3.78%
Conestoga Capital Advisors LLCas of 31 Dec 20232.15m3.72%
Fuller & Thaler Asset Management, Inc.as of 31 Dec 20231.42m2.45%
Dimensional Fund Advisors LPas of 31 Dec 20231.31m2.26%
Macquarie Investment Management Business Trustas of 31 Dec 20231.28m2.21%
Geode Capital Management LLCas of 31 Dec 20231.25m2.16%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.